PUR-5700

N/A

Report date: 2025/11/27 14:48:26
NME

Base Information

Drug NamePUR-5700
Drug Alias NameRV-7031PUR-5700
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRespivert Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPulmatrix IncRespivert Ltd
Active IndicationsN/A
Inactive IndicationsIdiopathic Pulmonary FibrosisPulmonary Disease, Chronic ObstructiveAsthma

Other Information

ATC CodeN/A
Related LinksN/A